Development and validation of a severity scale for leprosy type 1 reactions
about
A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairmeA Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in EthiopiaCirculating levels of insulin-like growth factor-I (IGF-I) correlate with disease status in leprosy.Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols.Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactionsLongitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal.Impact of a Reference Center on Leprosy Control under a Decentralized Public Health Care Policy in Brazil.AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findingsA leprosy clinical severity scale for erythema nodosum leprosum: An international, multicentre validation study of the ENLIST ENL Severity Scale.Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial.Development of the Adult Vulvar Lichen Sclerosus Severity Scale-A Delphi Consensus Exercise for Item Generation.
P2860
Q28477712-C0074319-A6F9-42AD-86A0-2DDABB46F3FFQ28551160-4143B2EE-6740-4B4D-B524-E5AD0F96945FQ34099919-2ABE0889-56A6-47CF-BDB8-AEE7C7FA1281Q34514916-F4A3FDF8-D582-47A4-9E65-0517FBF86ACCQ35066443-CF8FA4AA-BBDE-4562-B20E-F44215D998F0Q35825015-0872F4F0-B6B5-4322-AB04-7FED1D159BE9Q36161408-64E45C48-2E2E-4CD7-8787-AE92BD09F4BFQ36328107-442F4458-22DE-41EE-AEB7-07D62CDAEF83Q39569953-3126617F-19E3-4337-A4CA-4FCA32C27382Q42695916-F38147FC-4E6A-4236-92E8-FCC55C3B9942Q48563115-4F6D88A1-9B42-4994-98D3-DF806786F1AD
P2860
Development and validation of a severity scale for leprosy type 1 reactions
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Development and validation of a severity scale for leprosy type 1 reactions
@ast
Development and validation of a severity scale for leprosy type 1 reactions
@en
Development and validation of a severity scale for leprosy type 1 reactions
@nl
type
label
Development and validation of a severity scale for leprosy type 1 reactions
@ast
Development and validation of a severity scale for leprosy type 1 reactions
@en
Development and validation of a severity scale for leprosy type 1 reactions
@nl
prefLabel
Development and validation of a severity scale for leprosy type 1 reactions
@ast
Development and validation of a severity scale for leprosy type 1 reactions
@en
Development and validation of a severity scale for leprosy type 1 reactions
@nl
P2093
P2860
P3181
P1476
Development and validation of a severity scale for leprosy type 1 reactions
@en
P2093
Anna M Sales
C Ruth Butlin
Emanuel Rangel
Hemanto K Roy
Jose Augusto C Nery
Peter G Nicholls
Stephen L Walker
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0000351
P407
P577
2008-01-01T00:00:00Z